Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now LSE - Delayed Quote • USD Tvardi Therapeutics, Inc. (0HTC.L) Follow Add holdings 5.33 -0.01 (-0.22%) As of April 15 at 5:20:11 PM GMT+1. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 0HTC.L 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 0HTC.L View More All News Press Releases SEC Filings Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Connection with the Proposed Merger with Tvardi Therapeutics Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split Cara Therapeutics and Tvardi Therapeutics Announce Entry into Merger Agreement Tessera gets sickle cell funding; Corvus shares slide on eczema data Cara Therapeutics Third Quarter 2024 Earnings: Beats Expectations Cara: Q3 Earnings Snapshot Cara: Q2 Earnings Snapshot Cara Therapeutics Announces Exploration of Strategic Alternatives Chipotle, McDonald's initiated: Wall Street's top analyst calls Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica Cara Therapeutics (CARA) Reports Q1 Loss, Misses Revenue Estimates